A hot thyroid nodule is a lump in the thyroid gland that produces hormones on its own, independent of the brain’s normal signaling system. It gets its name from how it appears on a nuclear medicine scan: the nodule “lights up” brightly because it absorbs more radioactive tracer than the surrounding tissue. Unlike most thyroid nodules, which are inactive or underactive, a hot nodule is overactive and can eventually push your body into a state of excess thyroid hormone.
How a Hot Nodule Works
Your thyroid normally takes orders from the pituitary gland, which releases a messenger called TSH (thyroid-stimulating hormone). TSH tells the thyroid how much hormone to make. A hot nodule ignores this system entirely. It produces thyroid hormones whether the pituitary asks for them or not, a behavior doctors call “autonomy.”
Because the nodule is flooding the body with extra hormone, the pituitary responds by dialing TSH way down, sometimes to nearly undetectable levels. That drop in TSH causes the rest of the healthy thyroid tissue to slow down or stop working. So on a scan, the hot nodule glows while the surrounding gland fades into the background. This contrast is the hallmark image that identifies a hot nodule.
How It’s Detected
Hot nodules are identified through a thyroid scintigraphy scan, which uses a small amount of radioactive tracer (typically technetium-99m or radioactive iodine). After the tracer is injected or swallowed, a camera captures how much each part of the thyroid absorbs. Areas of high uptake appear “hot” on the image, while areas of low uptake appear “cold.” A hot nodule concentrates the tracer intensely compared to the normal tissue around it.
Blood tests usually show a pattern consistent with the scan: low or suppressed TSH, and elevated levels of the thyroid hormones T3 and T4. Some hot nodules produce enough hormone to cause obvious symptoms, while others create only mild lab abnormalities without noticeable effects. These subclinical cases still warrant monitoring because they can progress over time.
Symptoms of an Overactive Nodule
When a hot nodule produces enough excess hormone to affect the body, it causes the same constellation of symptoms as any form of hyperthyroidism. The most common include unintentional weight loss, a rapid or irregular heartbeat, hand tremors, anxiety or nervousness, difficulty sleeping, and increased sensitivity to heat. Some people notice fine, brittle hair or more frequent bowel movements.
Older adults often experience subtler signs that are easy to dismiss: fatigue, depression, weakness during everyday activities, or an irregular heartbeat without the classic jitteriness. This is sometimes called “apathetic hyperthyroidism,” and it can delay diagnosis because the symptoms look nothing like what most people expect from an overactive thyroid.
Cancer Risk in Hot Nodules
For years, the conventional wisdom was that hot nodules are almost never cancerous. That assumption has come under scrutiny. A systematic review and meta-analysis found that reported malignancy rates in hot nodules range widely, from less than 1% to as high as 44% in surgical series, depending on the study population and how aggressively biopsies were pursued. In studies that specifically examined single hot nodules, cancer rates ranged from 0% to 44%, while in patients with multiple overactive nodules the range was 0% to 26%.
These numbers don’t mean hot nodules are commonly cancerous. The higher figures come from studies where patients were already selected for surgery, which skews the sample toward suspicious cases. Still, the data challenges the old assumption that a hot nodule can be automatically considered benign. Many specialists now recommend evaluating hot nodules with ultrasound and, if the imaging shows concerning features, proceeding with a biopsy rather than dismissing the nodule based on its scan appearance alone.
What Happens Without Treatment
Left untreated, a hot nodule that is producing excess hormone can cause real damage over time. Prolonged hyperthyroidism strains the heart, increasing the risk of atrial fibrillation and other forms of cardiac dysfunction. It also accelerates bone loss, raising the risk of osteoporosis and fractures. Very large nodules can press on the windpipe, causing difficulty swallowing or breathing. In rare cases, a sudden surge in thyroid hormone can trigger a thyrotoxic crisis (sometimes called thyroid storm), a medical emergency with dangerously high heart rate, fever, and confusion.
Treatment Options
Radioactive Iodine
Radioactive iodine therapy is one of the most common treatments. You swallow a capsule containing a concentrated form of iodine that the overactive nodule absorbs preferentially, which gradually destroys the overproducing tissue. A single dose achieves success in 85% to 100% of patients with toxic nodular goiter and can shrink the nodule by up to 40%. The tradeoff is that the treatment often tips the thyroid into underactivity. In one study, about 38% of patients reached normal thyroid function six months after treatment, while 37% became hypothyroid and needed lifelong thyroid hormone replacement. The likelihood of becoming hypothyroid increases with higher doses.
Surgery
Surgical removal, usually a lobectomy (removing the half of the thyroid containing the nodule), is preferred when the nodule is very large, when there’s concern about cancer based on ultrasound or biopsy findings, or when the nodule is compressing nearby structures. Surgery provides an immediate solution and allows the tissue to be examined under a microscope. Recovery typically takes a few weeks, and if only one lobe is removed, the remaining thyroid tissue often produces enough hormone on its own.
Radiofrequency Ablation
A newer, minimally invasive option is radiofrequency ablation (RFA), which uses heat delivered through a needle to destroy nodule tissue without removing the thyroid. In a U.S. study, RFA reduced the volume of overactive nodules by a median of about 71%, and 75% of patients saw their TSH levels return to the normal range within 12 months. The procedure is done under local anesthesia, typically as an outpatient visit, and preserves the rest of the thyroid gland. It’s increasingly available but not yet as widely offered as radioactive iodine or surgery.
Medication
Anti-thyroid medications can control hormone levels but don’t eliminate the nodule itself. They’re often used as a bridge, bringing hormone levels down before definitive treatment with radioactive iodine, surgery, or ablation. Long-term medication alone is generally not the preferred strategy for a hot nodule because the underlying autonomy persists, and symptoms return if the medication is stopped.
Hot Nodules vs. Cold Nodules
The terms “hot” and “cold” describe function, not danger. A cold nodule doesn’t absorb tracer on a scan, meaning it’s not producing hormone. Cold nodules are far more common and carry a higher baseline suspicion for cancer, which is why they’re usually biopsied. A hot nodule absorbs more tracer than normal tissue, confirming it’s hormonally active. While hot nodules have traditionally been considered lower risk for malignancy, as noted above, that assumption isn’t absolute. A nodule can even be hot in one area and cold in another, and in rare cases, cancer has been found in the cold portion of a mixed nodule while the hot portion was benign.
It’s also possible, though uncommon, for a person to have both a hot and a cold nodule in the same thyroid gland simultaneously. In these cases, each nodule needs to be evaluated on its own terms.